Video: Artificial Intelligence Dominates ARVO Retina Sessions

Nearly half of the retina program is related to artificial intelligence, according to ARVO program co-chair Amitha Domalpally, MD, PhD. Other areas of interest include real-world anti-VEGF data and regenerative medicine.

By: Amitha Domalpally, MD, PhD

Retinal Physician April 29, 2026

-0:00/0:00

Amitha Domalpally, MD, PhD

Research Director, Wisconsin Reading Center

Affiliations: University of Wisconsin–Madison

Specialties: Ophthalmology

Bio: Amitha Domalpally, MD, PhD, is research director of the Wisconsin Reading Center at the University of Wisconsin–Madison. She also serves as retina chair for the ARVO annual meeting program committee. Her work and meeting leadership focus on retina research themes including artificial intelligence in clinical and clinical-trial settings, age-related macular degeneration, imaging biomarkers, functional testing, real-world anti-VEGF data, regenerative medicine, inherited retinal disease, gene therapy, diabetes, and vascular retinopathies.

PentaVision

Retinal Physician

Video: Artificial Intelligence Dominates ARVO Retina Sessions

Recommendations